Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1878, 2004; 10.1373/clinchem.2004.037275
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barassi, A.
Right arrow Articles by d’Eril, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barassi, A.
Right arrow Articles by d’Eril, G. M.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Infectious Disease
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2004;50:1878.)
© 2004 American Association for Clinical Chemistry, Inc.

Letters to the Editor

Biological Variation of Procalcitonin in Healthy Individuals

Alessandra Barassia, Francesco Pallotti and GianVico Melzi d’Eril

1 Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi dell’Insubria, Varese, Italy

aAddress correspondence to this author at: via Dunant 5, 21100 Varese, Italy. Fax 39-0332278565; e-mail alessandra.barassi@tin.it.

The first 20% of the full text of this article appears below.


To the Editor

Procalcitonin (PCT) is a stable 116-amino acid precursor molecule to the hormone calcitonin. High serum concentrations have been reported in patients with severe systemic bacterial or fungal, but not viral, infections (1).

Information on the biological variation of PCT is not available; this is limiting because the clinical utility of laboratory data can be affected by physiologic variation (2). Here we report the results of a study to determine the biological variation of PCT.

To investigate the biological variation of this analyte, we followed the same protocol that we used for the study of the biological variation of N-terminal pro-B-type . . . [Full Text of this Article]




eLetters:

Read all eLetters

Procalcitonin in healthy individuals
Nils G Morgenthaler, et al.
Clinical Chemistry Online, 5 Oct 2004 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.